protectplatelets.com redirects to tavalissehcp.com. This page describes the site that domain now serves; the primary profile lives at tavalissehcp.com.
AI visibility score
4.4/ 10Fair

▼ 0.6 since Jul 2026

#584,529 of 923,481 in Healthcare

As of 2026-08-01 · Engagemii indexCheck another site →The index →

AI Visibility Scorecard

TAVALISSE® (fostamatinib disodium hexahydrate) tablets

TAVALISSE® (fostamatinib disodium hexahydrate) tablets

Unclaimed

protectplatelets.com · Healthcare

Borderline visible. AI bots can crawl TAVALISSE® (fostamatinib disodium hexahydrate) tablets, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.

AI engines read this profile 5 times

Apple Intelligence · Meta AI · Claude

#584,529 of 923,481 in Healthcare for AI visibility

4

AEO Visibility

i

Borderline · 4.4/10

5

Muse Index Score

i

AI agent readiness

Basic · 5/100

0

AI Adoption

i

None detected · 0/100

Share

About TAVALISSE® (fostamatinib disodium hexahydrate) tablets

from our crawl and measurement

TAVALISSE® (fostamatinib disodium hexahydrate) tablets, based in South San Francisco, CA, describes itself simply: "Access HCP safety, dosing, efficacy, MOA, and support information for TAVALISSE, a chronic immune thrombocytopenia (ITP) treatment option." When AI engines look at it, they find little to work with. It scores 4.4 out of 10.

Our crawl found structured data on the page (Drug), a sitemap and a readable heading structure. It is missing an llms.txt file.

AI crawlers have visited 3 times in our tracking, including Applebot (Siri) and ClaudeBot (Anthropic).

Industry · Healthcare
Last scored · Aug 1, 2026

The 6 signals AI reads

Strong · Good · Fair · Weak

Structured Data

Weak

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Strong

Clear headings and answer-style content.

Entity Clarity

Strong

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Weak

Experience, Expertise, Authority, Trust markers.

Technical AEO

Good

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Good

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

Weak

No inbound links found yet.

Domain Authority

Weak

Little domain authority yet.

Reference Presence

Weak

Not in AI knowledge graphs yet.

News & Press

Weak

No press coverage found yet.

Community

Weak

No community discussion yet.

Social Mentions

Weak

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.4/10, TAVALISSE® (fostamatinib disodium hexahydrate) tablets is crawlable but under-signaled - fixable, and the signals above are where to start.

Is this your brand?

✓

The exact fixes for TAVALISSE® (fostamatinib disodium hexahydrate) tablets

✓

Which AI engines already crawl you

✓

Free AI bot monitoring: see every AI crawler that visits you

Already have an account? Sign in

Picked for TAVALISSE® (fostamatinib disodium hexahydrate) tablets: How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for TAVALISSE® (fostamatinib disodium hexahydrate) tablets.

Source & Attribution

Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/protectplatelets

Cite this score: Engagemii (2026). "AEO Score for TAVALISSE® (fostamatinib disodium hexahydrate) tablets." Retrieved from https://engagemii.com/aeo/brands/protectplatelets

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform